FIELD: organic chemistry, medicine, biochemistry, pharmacy.
SUBSTANCE: invention relates to benzamide derivatives possessing with inhibitory activity with respect to tyrosine kinase Flt-1-receptors VEGF that can be used in treatment of neoplastic disease. Invention describes a pharmaceutical substance comprising compounds of the group 2-[(4-pyridyl)methyl]-amino-N-[R1]-benzamide wherein R1 means 4-chlorophenyl, 4-methylphenyl, 4-chloro-3-(trifluoromethyl)phenyl or 3-(trifluoromethyl)phenyl possessing with the inhibitory activity with respect to tyrosine kinase Flt5-2-receptors VEGF associated with neoplastic disease and angiogenesis. Also, invention describes novel compounds of the group 2-[(nitrogen-containing heterocycle)methyl]-amino-N-[R1]-benzamide wherein nitrogen-containing heterocycle is represented by 4-pyrodyl, 4- or 5-quinolinyl, 2-imidazolyl, and a method for their synthesis. Also, invention describes a pharmaceutical composition comprising abovementioned compounds possessing the inhibitory activity with respect to tyrosine kinase VEGF receptors used in treatment of neoplastic disease.
EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.
17 cl, 2 tbl, 74 ex
Title | Year | Author | Number |
---|---|---|---|
ANTHRANILIC ACID AMIDES AND THEIR USING IN PHARMACEUTICALS | 2002 |
|
RU2315756C2 |
NEW ANTHRANILAMIDOPYRIDINEUREAS AS VEGF RECEPTOR KINASE INHIBITORS | 2005 |
|
RU2415850C2 |
ANTHRANILIC ACID AMIDES, METHOD FOR THEIR PREPARING AND THEIR USING, METHOD FOR TREATMENT OF NEOPLASM DISEASE AMD PHARMACEUTICAL DRUG POSSESSING INHIBITORY ACTIVITY WITH RESPECT TO TYROSINE KINASE VEGF RECEPTOR | 2002 |
|
RU2318811C2 |
TYROSINE KINASE INHIBITORS | 2008 |
|
RU2445309C2 |
ANTHRANILIC ACID ORTHO-SUBSTITUTED AMIDES AND THEIR USING AS MEDICINAL AGENTS | 2001 |
|
RU2264399C2 |
ANTHRANYLAMIDEPYRIDINE AMIDES WITH SELECTIVE EFFECT AS INHIBITORS OF VEGFR-2 AND VEGFR-3 | 2002 |
|
RU2299208C2 |
SUBSTITUTED AMIDES OF BENZOIC ACID AND PHARMACEUTICAL PREPARATION CONTAINING THEM | 2001 |
|
RU2353618C2 |
COMBINATIONS AND COMPOSITIONS EFFECTING ON FUNCTION OF VEGF/VEGF RECEPTOR AND ANGIOPOIETIN/TIE(II) RECEPTOR SYSTEMS AND USES THEREOF | 2001 |
|
RU2292221C2 |
PHTHALAZINES ELICITING ANGIOGENESIS INHIBITORY ACTIVITY | 1998 |
|
RU2207132C2 |
DERIVATIVES OF 2-AMINONICOTINE AMIDE AND THEIR USING AS INHIBITORS OF TYROSINE KINASE VEGF RECEPTORS | 2001 |
|
RU2296124C2 |
Authors
Dates
2006-10-27—Published
1999-11-08—Filed